Drug–polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide

References

• Kolašinac N, Kachrimanis K, Homšek I, et al. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 2012;436:161–170.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Meng F, Dave V, Chauhan H. Qualitative and quantitative methods to determine miscibility in amorphous drug–polymer systems. Eur J Pharm Sci. 2015;77:106–11.
   PubMed Web of Science ®Google Scholar
• Pajula K, Taskinen M, Lehto V-P, et al. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Mol Pharm. 2010;7:795–804.
   PubMed Web of Science ®Google Scholar
• Yu H, Hadinoto K. Mitigating the adverse effect of spray drying on the supersaturation generation capability of amorphous nanopharmaceutical powders. Powder Technol. 2015;277:97–104.
   Web of Science ®Google Scholar
• Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11:2662–2679.
   Web of Science ®Google Scholar
• Gulley JL. Prostate cancer. In: Abraham J, Gulley JL, editors. Emerging cancer therapeutics. Demos Medical Publishing; Vol. 2;1964.
   Google Scholar
• Meyer JL, Hinkelbein, W. Controversies in the treatment of prostate cancer. Moser L, Schostak, M., Miller, K., Hinkelbein, W., editor. Berlin: Karger Publishers; Vol. 41;2006.
   Google Scholar
• Elgindy N, Elkhodairy K, Molokhia A, et al. Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions. Drug Dev Ind Pharm. 2011;37:754–764.
   PubMed Web of Science ®Google Scholar
• Prasad D, Chauhan H, Atef E. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug–polymer interaction for synergistic effects. J Pharm Sci. 2014;103:3511–3523.
   PubMed Web of Science ®Google Scholar
• Dahlberg C, Millqvist-Fureby A, Schuleit M, et al. Polymer–drug interactions and wetting of solid dispersions. Eur J Pharm Sci. 2010;39:125–133.
   PubMed Web of Science ®Google Scholar
• Jones D. Pharmaceutical applications of polymers for drug delivery. Vol. 15. United Kingdom: iSmithers Rapra Publishing; 2004.
   Google Scholar
• Van Krevelen DW, Te Nijenhuis K. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. United Kingdom: Elsevier; 2009.
   Google Scholar
• Hansen CM. The universality of the solubility parameter. Ind Eng Chem Prod Res Dev. 1969;8:2–11.
   Web of Science ®Google Scholar
• Hansen CM. The three dimensional solubility parameter-key to paint component affinities – solvents, plasticizers, polymers, and resins. J Paint Technol. 1967;39:104–117.
   Google Scholar
• Raymond C RowePJSaMEQ. Handbook of Pharmaceutical Excipients. 6 ed. 2009.
   Google Scholar
• Kaminski GA, Maple JR, Murphy RB, et al. Pseudospectral local second-order Møller–Plesset methods for computation of hydrogen bonding energies of molecular pairs. J Chem Theory Comput. 2005;1:248–254.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug–polymer miscibility and solubility. Pharm Res. 2006;23:2417.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Li T, Taylor LS. Estimation of drug–polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res. 2009;26:139.
   PubMed Web of Science ®Google Scholar
• Meng F, Trivino A, Prasad D, et al. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. Eur J Pharm Sci. 2015;71:12–24.
   PubMed Web of Science ®Google Scholar
• Tao J, Sun Y, Zhang GG, et al. Solubility of small-molecule crystals in polymers: d-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. Pharm Res. 2009;26:855–864.
   PubMed Web of Science ®Google Scholar
• Trasi NS, Taylor LS. Effect of additives on crystal growth and nucleation of amorphous flutamide. Cryst Growth Des. 2012;12:3221–3230.
   Web of Science ®Google Scholar
• Elgindy, N, Elkhodairy, K, Molokhia, A, et al. Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation. Drug Development and Industrial Pharmacy. 2011;37:446–455. doi:10.3109/03639045.2010.522190
   PubMed Web of Science ®Google Scholar
• Archer WL. Hansen solubility parameters for selected cellulose ether derivatives and their use in the pharmaceutical industry. Drug Dev Ind Pharm. 1992;18:599–616.
   Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int J Pharm. 2007;328:119–129.
   PubMed Web of Science ®Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, et al. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci. 1999;88:1182–1190.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang G, Neilly J, et al. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm. 2004;286:69–80.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Helmy MW, Samy WM, et al. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: formulation, characterization, and in vivo pharmacokinetics. Eur J Pharm Biopharm. 2013;84:487–496.
   PubMed Web of Science ®Google Scholar
• Papadimitriou SA, Barmpalexis P, Karavas E, et al. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I. European Journal of Pharmaceutics and Biopharmaceutics. 2012;82:175–186. doi:10.1016/j.ejpb.2012.06.003
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
   PubMed Web of Science ®Google Scholar
• Chauhan H, Hui-Gu C, et al. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci. 2013;102:1924–1935.
   PubMed Web of Science ®Google Scholar
• Chauhan H, Kuldipkumar A, Barder T, et al. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction. Pharm Res. 2014;31:500–515.
   PubMed Web of Science ®Google Scholar
• Ginés J, Arias M, Rabasco A. Elaboration and dissolution study of solid dispersions triamterene-d-mannitol. Summary of Presentations Congressus Pharmaceuticus Hungaricus IX; Budapest; 1993. p. 19–22.
   Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.
   PubMed Web of Science ®Google Scholar
• Mariappan G, Sundaraganesan N. Spectral and structural studies of the anti-cancer drug Flutamide by density functional theoretical method. Spectrochim Acta A: Mol Biomol Spectrosc. 2014;117:604–613.
   PubMed Web of Science ®Google Scholar